Jasper Therapeutics (JSPR) Financials

$0.66

$-0.04 (-5.77%)

As on 11-Sep-2026 16:01EDT

Market cap

$22 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

16.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	13.51	6.20
Cost of Revenue	0.31	1.06	1.37	1.11	1.31	0.57
Gross Profit	-0.31	-1.06	-1.37	-1.11	-1.31	-0.57
Operating Expenses	55.14	79.46	76.24	68.86	51.20	36.83
Operating Profit (EBIT)	-55.16	-80.52	-76.24	-68.86	-51.20	-36.83
Other Income	--	--	--	--	--	--
Profit before Tax	-31.77	-75.80	-71.27	-64.47	-37.69	-30.64
Provision for Tax	--	--	-1.49	-1.63	-13.51	-1.10
Profit after Tax (Net Income)	-31.77	-75.80	-71.27	-64.47	-37.69	-30.64
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-37.69	-30.64

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1.41	4.15	61.67	78.44	35.99	69.52
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.54	18.43	2.99	4.08	5.31	16.12
Current Liabilities	7.85	13.20	15.24	12.37	7.07	8.02
Total Liabilities	19.65	35.78	79.90	94.89	48.36	93.65

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.23	1.13	4.09	5.95	6.63	5.82
Current Assets	11.57	34.65	75.81	88.94	41.73	87.83
Total Assets	19.65	35.78	79.90	94.89	48.36	93.65
Total Debt*	0.27	1.24	1.81	2.79	3.65	2.89
Net Current Assets	3.73	21.45	60.57	76.56	34.67	79.81

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-77.16	-62.60	-52.07	-45.86	-33.68
Cash Flow from Investing Activities	--	0.01	-0.53	-0.27	-0.58	-2.43
Cash from Financing Activities	--	34.21	47.88	100.97	0.06	100.97
Net Cash Inflow / Outflow	--	--	--	--	-46.38	64.86

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.58	-2.64	-4.75	-5.84	-10.28	-37.45
Cash EPS ($)	-0.88	-2.61	-4.66	-5.74	-10.02	-36.99
Adjusted Book Value ($)	0.05	0.14	4.11	7.10	9.82	84.99
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.69	-4.17	-4.71	-12.51	-41.17
Free Cash Flow per Share ($)	--	-2.69	-4.21	-4.74	-12.67	-44.14

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-220.12	-98.50	-106.67	-67.27	-157.53
ROE (%)	-1,142.02	-230.31	-101.73	-112.67	-71.44	-178.18
ROA (%)	-73.36	-131.06	-81.55	-90.00	-53.07	-52.37
EBIT Margin (%)	--	--	--	--	-278.92	-494.46
Net Margin (%)	--	--	--	--	-278.92	-494.46
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	1.18	--
EBIT Growth (%)	68.09	-6.36	-10.55	-71.06	-23.00	4.16
Net Profit Growth (%)	65.06	-6.36	-10.55	-71.06	-23.00	3.26
EPS Growth (%)	73.74	0.44	0.19	0.43	0.73	0.78
Book Value Growth (%)	-96.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.69	-4.50	-0.14	-0.05	-0.21
Price / Book Value	16.51	12.64	5.20	0.11	0.05	0.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.42	-0.33	-3.59	1.19	0.89	2.49
Close Price ($)	0.42	1.83	21.38	7.89	4.83	78.50
High Price ($)	7.19	22.52	31.01	38.00	87.00	188.80
Low Price ($)	0.32	1.39	6.41	4.00	3.86	70.30
Market Cap ($ Cr)	21.97	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.30	0.03	0.04	0.10	0.04
Short term debt to equity ratio	0.19	0.30	0.02	0.01	0.02	0.01
Current Ratio	1.47	2.62	4.98	7.19	5.91	10.95
Quick Ratio	1.47	--	--	--	--	11.02
Interest Coverage	--	--	--	--	-2.79	-4.94

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	8.58	11.27
Asset Turnover	--	--	--	--	0.19	0.11
Receivable days	--	--	--	--	25.10	38.26
Inventory Days	--	--	--	--	-152.79	-146.01
Payable days	--	1,772.12	1,087.50	975.26	792.82	1,721.71
Cash Conversion Cycle	--	--	--	--	-920.51	-1,829.46

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.